After patients go into remission, there may still be undetected cancer cells lying dormant through the body.

A study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that while blood-based tests offer a more convenient option for colorectal cancer screening, only 49% of patients completed a follow-up colonoscopy within six months, and just 56% did so at any point during the two-year study period.

The popular artificial sweetener sucralose—found both in packets and diet sodas—might not be the best choice for patients having cancer treatment.

A new resilience coaching program helped adolescents and young adults (AYA) with advanced cancer feel more hopeful and resilient, helping these individuals cope with their cancer, leading to lasting improvements in quality of life, according to study findings presented at the ASCO 2025 Annual Meeting.

Community oncology practices in the United States have been experiencing drug shortages that seriously impact cancer care delivery, according to a survey published in JCO Oncology Practice.

Kimberly (Cary) Demirhan, a registered nurse and assistant director of Education Programs at the Association of Cancer Care Centers, emphasized the importance of making clinical trials more accessible for patients receiving care in their own communities.

Doctors at the National Institutes of Health have discovered a new cause of skin cancer, according to a case report published Wednesday in the New England Journal of Medicine.

Hidden in the lungs of some breast cancer survivors are tumour cells that can remain dormant for decades — until they one day trigger a relapse. Now, experiments in mice show that these rogue cells can be roused from their slumber by common respiratory illnesses such as COVID-19 or the flu.

A federal judge has temporarily stopped Arkansas' first-in-the-nation law prohibiting pharmacy benefit managers from owning pharmacies from going into effect, the Arkansas Advocate first reported.

As July comes to an end, the conversation around prostate cancer is expanding, particularly in understanding what survivorship looks like for those with metastatic disease.